These differences between the cell lines could be due to different additional genomic alterations in these PDX lines; however, invasion and ECM gene expression were the core common pathways downregulated between these two lines, suggesting the acetylation of RelA/p65 plays a key regulatory switch in these GBM processes. The gene discussed is RELA; the disease is glioblastoma.